These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28573869)
21. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review. Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378 [TBL] [Abstract][Full Text] [Related]
22. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review. Hesse EM; Godfred-Cato S; Bower WA Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559 [TBL] [Abstract][Full Text] [Related]
23. A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers. Subramanian GM; Cronin PW; Poley G; Weinstein A; Stoughton SM; Zhong J; Ou Y; Zmuda JF; Osborn BL; Freimuth WW Clin Infect Dis; 2005 Jul; 41(1):12-20. PubMed ID: 15937757 [TBL] [Abstract][Full Text] [Related]
24. Monoclonal Antibodies Against Infectious Microbes: Raj GM; Priyadarshini R; Murugesan S; Adhimoolam M Infect Disord Drug Targets; 2021; 21(1):4-27. PubMed ID: 32164518 [TBL] [Abstract][Full Text] [Related]
25. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360 [TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results. Xu W; Ohanjanian L; Sun J; Cui X; Suffredini D; Li Y; Welsh J; Eichacker PQ PLoS One; 2017; 12(8):e0182879. PubMed ID: 28797061 [TBL] [Abstract][Full Text] [Related]
27. Post-exposure therapy of inhalational anthrax in the common marmoset. Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184 [TBL] [Abstract][Full Text] [Related]
28. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis. Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178 [TBL] [Abstract][Full Text] [Related]